دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
A new generation of long-lasting insecticidal nets
SimonKariukiaLunaKamaua
Two midwives during the second stage of labour to reduce severe perineal trauma
RebeckaDalbyeaHege HølmoJohannessenb
Evaluating COVID-19 vaccines in the real world
Edward JMillsaGilmarReisb
Meeting the health challenges of displaced populations from Ukraine
YuliaIoffeaIbrahimAbubakarbRitaIssacPaulSpiegeldBernadette NKumare
Monitoring inequalities is a key part of the efforts to end AIDS, tuberculosis, and malaria
Ahmad RezaHosseinpooraNicoleBergenaKatherineKirkbyaAnneSchlotheuberaCecilia VidalFuertesaStephen MacFeelyaSamiraAsmaa
UK Public Health Science 2022: a call for abstracts
RachelThomsonbCharlotteVrintenaUK Public Health Science Conference organising committeeâ€
Informing NCD control efforts in India on the eve of Ayushman Bharat
BalramBhargavaaVinod KPaulb
Seeking accountablity for Ukraine health-care attacks
SaleyhaAhsan
Martin Landray: harnessing the power of good clinical trials
UdaniSamarasekera
A different way of lookingRachel E Gross, Vagina Obscura: An Anatomical Voyage, W W Norton & Company (2022), p. 336, £19·99/US$30·00, ISBN: 9781324006312
RageshriDhairyawan
Historical perspectives on xenotransplantation
ThomasSchlichbBartLuttersa
Brazil's COVID-19 guidelines: political hijack of public health
Luis C LCorreiaaCristinaSettebMarisaSantoscCarlos A SMaglianocFotini SToscasd
Vaccine approval before phase 3 trial results: a consequence of vaccine access inequity
IsaacNúñeza
No point in travel bans if countries with poor surveillance are ignored
WolfgangPreiseraSusanEngelbrechtaTongaiMapongaa
Booster vaccines for COVID-19 vaccine breakthrough cases?
Douglas FNixonaRobert ESchwartzaLishomwa CNdhlovua
Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply
Philip RKrauseaHelenReesbJ PeterFigueroacSoumyaSwaminathandAna Maria HenaoRestrepod
WHO's surveillance system for attacks on health care is failing Ethiopia
Abel FDadiabTesfaye BMershac
Is open access a misnomer?
LaurenFloydMadelenaStaussAlexanderWoywodt
Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial
Jacklin FMoshaPhDa†Manisha AKulkarniPhDb†EliudLukoleMscaNancy SMatowoPhDcCatherinePittPhDdLouisa AMessengerPhDcElizabethMallyaBscfMohamedJumanneBscaTatuAzizBAaRobertKaayaMscfBoniface AShirimaBscfGladnessIsayaBscfMonicaTaljaardPhDbgJacklinMartinMscafRamadhanHashimMscaCharlesThickstunMscbAlphaxardManjuranoPhDaProfImmoKleinschmidtPhDehi…NatachaProtopopoffPhDc
The effect of two midwives during the second stage of labour to reduce severe perineal trauma (Oneplus): a multicentre, randomised controlled trial in Sweden
MalinEdqvistPhDadProfHannah GDahlenPhDfCeciliaHäggsgårdMScdHelenaTernMScdKarinÄngebyPhDghPiaTelemanPhDeiGunillaAjnePhDbcProfChristineRubertssonPhDd
Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study
AnalÃaRearteMDaJuan ManuelCastelliMDaRamiroRearteDrMVbNoraFuentesMDcVelenPenniniMScaMartinaPesceMDaPilar BarcenaBarbeiraMDaLuciana EvaIummatoMScaMelisaLauroraMAaMarÃa LucÃaBartolomeuMScaGuidoGalliganiMDaMarÃaDel Valle JuarezMDaCarlos MarÃaGiovacchiniMScaAdriánSantoroMScaMarianoEsperattiMDdSoniaTarragonaMScaCarlaVizzottiMDa
Extraskeletal Ewing sarcoma of the duodenum presenting as duodenojejunal intussusception
RazeenHassanMDaLeow VoonMengMMedSurgacKee ThianNgeeMDaLimI-VernMSurgaPadmaanSankaranMSurgaLim ChoonHeanMSurgaLeeEuxianMMedSurgaHaidiMohamadMPathbNoraini MohdDusaMPathdManisekarSubramaniamFRCS (Edin)a
NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries
NCD Countdown 2030 collaboratorsâ€
